Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis

Table 2 Baseline characteristics of the lowest and highest HbA1c group

Baseline characterization	Lowest	Highest	Total number
Baseline characterization	Lowest	Highest	Lowest	Highest
Male (%), studies = 19	71.69%	73.45%	45,354	10,909
Age (year), studies = 19	61.25602	62.03319	45,354	10,909
Smoker (%), studies = 15	42.25%	39.54%	43,277	9681
BMI (kg/m²), studies = 11	25.87935	26.00163	283	301
BMI > 30 kg/m² (%), studies = 2	21.15%	22.22%	52	63
Previous MI (%), studies = 11	16.73%	15.57%	39,307	8737
Hypertension (%), studies = 15	38.52%	43.27%	9157	4708
Heart failure (%), studies = 3	5.24%	5.79%	36,565	6925
Cerebrovascular accident (%), studies = 6	4.96%	5.58%	37,262	7281
Hyperlipidemia (%), studies = 10	47.72%	41.92%	41,808	7855
Renal insufficiency (%), studies = 3	26.47%	25.35%	774	447
Antiplatelet (%), studies = 2	17.47%	20.54%	596	294
Aspirin (%), studies = 2	34.50%	33.60%	35,325	5952
Clopidogrel (%), studies = 2	7.69%	8.35%	35,325	5952
PCI (%), studies = 6	8.42%	10.78%	3031	2283
CABG (%), studies = 4	2.43%	4.08%	1745	1323
ACEI/ARB (%), studies = 4	27.97%	34.02%	36,013	6276
Lipid lowering drugs (%), studies = 4	27.76%	25.24%	36,013	6276
Beta-blocker (%), studies = 3	26.39%	27.11%	35,901	6194
Creatinine (mg/dl), studies = 4	1.259,418	1.105723	1388	1839
eGFR (mg/dl/1.73 m²), studies = 5	87.00478	68.16183	5507	1654
Admission plasma glucose, studies = 11	7.84536	9.461979	4831	4171
Killip ≥ 3 (%), studies = 3	11.75%	14.33%	1081	1584
Killip ≥ 2 (%), studies = 8	9.88%	16.68%	5782	1915

BMI body mass index, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blocker, eGFR estimated glomerular filtration rate

ISSN: 1475-2840